IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 65 filers reported holding IRADIMED CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $681 | +154.1% | 15,514 | +154.0% | 0.00% | – |
| Q1 2024 | $268 | -10.4% | 6,108 | -3.3% | 0.00% | – |
| Q4 2023 | $299 | +12.0% | 6,318 | +4.9% | 0.00% | – |
| Q3 2023 | $267 | +7.7% | 6,025 | +15.9% | 0.00% | – |
| Q2 2023 | $248 | +25.3% | 5,198 | +2.8% | 0.00% | – |
| Q1 2023 | $198 | +23.0% | 5,055 | -11.2% | 0.00% | – |
| Q4 2022 | $161 | -99.9% | 5,692 | +0.2% | 0.00% | – |
| Q3 2022 | $170,000 | -12.4% | 5,680 | -0.8% | 0.00% | – |
| Q2 2022 | $194,000 | +104.2% | 5,724 | +168.6% | 0.00% | – |
| Q1 2022 | $95,000 | 0.0% | 2,131 | +3.3% | 0.00% | – |
| Q4 2021 | $95,000 | +295.8% | 2,063 | +150.4% | 0.00% | – |
| Q2 2021 | $24,000 | +71.4% | 824 | +27.0% | 0.00% | – |
| Q4 2020 | $14,000 | -17.6% | 649 | -18.9% | 0.00% | – |
| Q3 2020 | $17,000 | -59.5% | 800 | -55.9% | 0.00% | – |
| Q2 2020 | $42,000 | -4.5% | 1,815 | -13.3% | 0.00% | – |
| Q1 2020 | $44,000 | +158.8% | 2,093 | +184.4% | 0.00% | – |
| Q4 2019 | $17,000 | +88.9% | 736 | +67.3% | 0.00% | – |
| Q3 2019 | $9,000 | – | 440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
| Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
| RK Capital | 211,325 | $4,512,000 | 2.03% |
| Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
| Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
| CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
| ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
| Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
| GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |